Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

United Kingdom

 

Private hospitals face big drop in profits in England

The Department of Health has proposed steep cuts in tariffs for elective orthopaedic surgery in the year to April 2016. That is bad news for private sector players such as Horder, Ramsay and Circle. BMI, Spire and Nuffield will also be hit. In total, the moves should cut private sector revenues from the NHS by £49m. We look at who stands to lose the most.

Shared medical appointments can supercharge productivity

How do you see 12 patients an hour instead of three patients every two hours and improve outcomes at the same time? One idea might be to take a look at shared medical appointments (SMAs). The idea is being implemented at groups from the Cleveland Clinic in the US, to Aravind Eye Hospitals in India and an NHS mental health trust in East London.

Report: Healthcare Europa Property Survey 2015

There is intense investor interest in healthcare services property across Europe. Fund manager Marc Phillip Martins-Kuenzel, at German real estate investor Corpus Sireo claims that he had 400 approaches from prospective buyers in a single year. This reflects the global search for high yielding investments. But healthcare property also carries risks. Some sectors such as the French hospital market, where major deals have been done, look risky as the government cuts tariffs. And the sector remains opaque and poorly segmented. There are plenty of traps for the unwary. It is also far from clear how much new capacity will come on stream for investors over the next decade. Here we look at whether and when the boom will go bust. First, we run through the headlines and what has happened to prices. We then go on to look at supply and demand. Other articles profile the main US and European property investors and the main national markets.

UK homecare? No thanks!

Long-term NHS contracts make much of the UK homecare sector unattractive. Duke Street is trying to sell Baywater Healthcare, its COPD and sleep apnea business, and Bupa has been running the slide rule over its Bupa Home Healthcare arm.

babylon health to launch “revolutionary” AI within a month

The innovative UK telehealth business, babylon health, will launch its hotly anticipated artificial intelligence (AI) programme within a month, says its founder and CEO Dr Ali Parsa. It will use computer pattern recognition to diagnose common illnesses, making diagnosis effectively a free service. We talk to Parsa about the business, which plans to roll out its service through the English NHS as well as in the Bahamas, but appears to have postponed its entry to Rwanda.

Risebrow to help companies sell to the NHS

Hugh Risebrow, the former UK managing director of lab group synlab UK and former commercial director at Guy’s and St Thomas’s NHS Foundation Trust has become CEO of UK consultancy Latchmore Associates. He hopes to help healthcare service companies set up base in the UK and to sell their services to the NHS.

Pihlajalinna launches more JVs after IPO

Pihlajalinna, the Finnish healthcare and social services outfit, which recently IPOed with a market capitalisation of €255m, has struck a third joint venture with Finnish municipalities to outsource health and social services. Finland is likely to open up even more to the private sector under the current government.

Unilabs achieves 7% organic growth

Unilabs CEO and company doctor Jos Lamers is cock-a-hoop over second quarter sales growth of 7.1% at constant exchange rates and sees a trend towards the public sector outsourcing. Unilabs, the Pan-West European lab and imaging group, was a late entry in to the race to buy Pan-Euro lab group synlab this summer and Lamers is keen to make more acquistions. We talk to him about the results and how he sees the lab sector.

Find Us